FR2035119A1 - - Google Patents

Info

Publication number
FR2035119A1
FR2035119A1 FR7010070A FR7010070A FR2035119A1 FR 2035119 A1 FR2035119 A1 FR 2035119A1 FR 7010070 A FR7010070 A FR 7010070A FR 7010070 A FR7010070 A FR 7010070A FR 2035119 A1 FR2035119 A1 FR 2035119A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7010070A
Other languages
French (fr)
Other versions
FR2035119B1 (enrdf_load_html_response
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of FR2035119A1 publication Critical patent/FR2035119A1/fr
Application granted granted Critical
Publication of FR2035119B1 publication Critical patent/FR2035119B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
FR7010070A 1969-03-20 1970-03-20 Expired FR2035119B1 (enrdf_load_html_response)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1467169A GB1291282A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FR2035119A1 true FR2035119A1 (enrdf_load_html_response) 1970-12-18
FR2035119B1 FR2035119B1 (enrdf_load_html_response) 1974-08-30

Family

ID=10045477

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7010070A Expired FR2035119B1 (enrdf_load_html_response) 1969-03-20 1970-03-20

Country Status (6)

Country Link
BE (1) BE747657A (enrdf_load_html_response)
CA (1) CA930305A (enrdf_load_html_response)
DE (1) DE2013040A1 (enrdf_load_html_response)
ES (1) ES377723A1 (enrdf_load_html_response)
FR (1) FR2035119B1 (enrdf_load_html_response)
GB (1) GB1291282A (enrdf_load_html_response)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181804A1 (enrdf_load_html_response) * 1972-03-08 1973-12-07 Bayer Ag
EP0091502A1 (en) * 1982-04-13 1983-10-19 Asahi Kasei Kogyo Kabushiki Kaisha A pharmaceutical preparation of cephalosporin for rectal administration

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794798A (en) * 1955-09-22 1958-05-07 Nathaniel Mandel Elias Pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794798A (en) * 1955-09-22 1958-05-07 Nathaniel Mandel Elias Pharmaceutical compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181804A1 (enrdf_load_html_response) * 1972-03-08 1973-12-07 Bayer Ag
EP0091502A1 (en) * 1982-04-13 1983-10-19 Asahi Kasei Kogyo Kabushiki Kaisha A pharmaceutical preparation of cephalosporin for rectal administration

Also Published As

Publication number Publication date
GB1291282A (en) 1972-10-04
BE747657A (fr) 1970-09-21
FR2035119B1 (enrdf_load_html_response) 1974-08-30
DE2013040A1 (de) 1970-11-26
ES377723A1 (es) 1972-10-16
CA930305A (en) 1973-07-17

Similar Documents

Publication Publication Date Title
AU2270770A (enrdf_load_html_response)
CS151539B2 (enrdf_load_html_response)
AU429630B2 (enrdf_load_html_response)
AU5461069A (enrdf_load_html_response)
AU442375B2 (enrdf_load_html_response)
FR2035119B1 (enrdf_load_html_response)
AU427401B2 (enrdf_load_html_response)
CS148431B1 (enrdf_load_html_response)
AU442380B2 (enrdf_load_html_response)
AU442322B2 (enrdf_load_html_response)
AU442285B2 (enrdf_load_html_response)
AU442357B2 (enrdf_load_html_response)
AU438128B2 (enrdf_load_html_response)
AU442538B2 (enrdf_load_html_response)
AU428129B2 (enrdf_load_html_response)
AU442535B2 (enrdf_load_html_response)
AU442463B2 (enrdf_load_html_response)
AU425297B2 (enrdf_load_html_response)
AU5988769A (enrdf_load_html_response)
AU5228269A (enrdf_load_html_response)
CS150489B1 (enrdf_load_html_response)
CS148836B1 (enrdf_load_html_response)
AU5077469A (enrdf_load_html_response)
AU4923469A (enrdf_load_html_response)
AU436893A (enrdf_load_html_response)